UBS Group’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-617
| Closed | -$1.23K | – | 10418 |
|
|
2023
Q1 | $1.23K | Sell |
617
-101
| -14% | -$299 | ﹤0.01% | 8776 |
|
|
2022
Q4 | $2.62K | Sell |
718
-252
| -26% | -$1.07K | ﹤0.01% | 9651 |
|
|
2022
Q3 | $4K | Buy |
970
+714
| +279% | +$5.08K | ﹤0.01% | 9486 |
|
|
2022
Q2 | $2K | Sell |
256
-571
| -69% | -$5.33K | ﹤0.01% | 9747 |
|
|
2022
Q1 | $10K | Buy |
827
+102
| +14% | +$1.3K | ﹤0.01% | 8496 |
|
|
2021
Q4 | $12K | Buy |
725
+649
| +854% | +$13.7K | ﹤0.01% | 8623 |
|
|
2021
Q3 | $2K | Sell |
76
-108
| -59% | -$3.25K | ﹤0.01% | 9072 |
|
|
2021
Q2 | $6K | Sell |
184
-307
| -63% | -$12.2K | ﹤0.01% | 8490 |
|
|
2021
Q1 | $24K | Buy |
491
+120
| +32% | +$6.96K | ﹤0.01% | 7223 |
|
|
2020
Q4 | $18K | Sell |
371
-100
| -21% | -$3.76K | ﹤0.01% | 7033 |
|
|
2020
Q3 | $17K | Sell |
471
-180
| -28% | -$10.1K | ﹤0.01% | 6456 |
|
|
2020
Q2 | $45K | Buy |
651
+171
| +36% | +$6.82K | ﹤0.01% | 5945 |
|
|
2020
Q1 | $11K | Buy |
+480
| New | +$11.5K | ﹤0.01% | 6894 |
|
|
2019
Q4 | – | Sell |
-357
| Closed | -$4K | – | 8545 |
|
|
2019
Q3 | $4K | Sell |
357
-349
| -49% | -$3.1K | ﹤0.01% | 7584 |
|
|
2019
Q2 | $6K | Buy |
+706
| New | +$7.19K | ﹤0.01% | 7343 |
|
|
2019
Q1 | – | Sell |
-499
| Closed | -$4K | – | 8342 |
|
|
2018
Q4 | $4K | Buy |
499
+437
| +705% | +$7.66K | ﹤0.01% | 7662 |
|
|
2018
Q3 | $1K | Buy |
+62
| New | +$2.36K | ﹤0.01% | 7878 |
|
|
2018
Q1 | – | Sell |
-299
| Closed | -$14K | – | 8288 |
|
|
2017
Q4 | $14K | Sell |
299
-475
| -61% | -$25.2K | ﹤0.01% | 6826 |
|
|
2017
Q3 | $48K | Buy |
774
+509
| +192% | +$29.8K | ﹤0.01% | 5828 |
|
|
2017
Q2 | $17K | Buy |
265
+198
| +296% | +$11K | ﹤0.01% | 6427 |
|
|
2017
Q1 | $5K | Sell |
67
-321
| -83% | -$35.7K | ﹤0.01% | 7010 |
|
|
2016
Q4 | $58K | Buy |
388
+15
| +4% | +$2.65K | ﹤0.01% | 5711 |
|
|
2016
Q3 | $74K | Buy |
373
+181
| +94% | +$33.3K | ﹤0.01% | 5207 |
|
|
2016
Q2 | $36K | Buy |
+192
| New | +$41.8K | ﹤0.01% | 5787 |
|
UBS Group's NH Position: Q2 2023 in Review
UBS Group sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 617 shares — an estimated $1.23K sold.
UBS Group first reported a position in NH in Q2 2016 and held it in 24 quarters. The position peaked at $74K in Q3 2016. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.
- UBS Group reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
- UBS Group sold 617 NantHealth, Inc shares in Q2 2023, an estimated $1.23K.
- UBS Group first reported a position in NantHealth, Inc in Q2 2016 and held it in 24 quarters.
- UBS Group's NantHealth, Inc position peaked at $74K in Q3 2016.
- 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.